Literature DB >> 28420554

The incidence and clinical associated factors of interval colorectal cancers in Southern Taiwan.

Cheng-En Tsai1, Keng-Liang Wu2, Yi-Chun Chiu3, Seng-Kee Chuah3, Wei-Chen Tai1, Ming-Luen Hu1, Chih-Ming Liang1.   

Abstract

BACKGROUND/
PURPOSE: Interval colorectal cancer (CRC) is an emerging issue in CRC screening and surveillance. The frequency of interval CRC and its associated factors have not been well studied in Eastern Asia. We aim to clarify the factors associated with interval CRC.
METHODS: CRC patients who had negative colonoscopy results 6-36 months prior to cancer diagnosis were defined as cases of interval CRC. Patient characteristics, past history, colon preparation, colonoscopy findings, and pathology were retrospectively evaluated. A total of 670 patients with colorectal adenocarcinoma by pathology who also underwent colonoscopy before diagnosis from January 2005 to November 2014 were recruited.
RESULTS: Twenty-two (3.28%) patients (65.7 ± 9.2 years old; 9 male) were diagnosed with interval CRC. The interval CRCs were predominantly located at the rectum and cecum, and presented as earlier stage cancers (Stage I and Stage II: 86.4%, Stage III and Stage IV: 13.6%). Factors associated with interval cancer include end-stage renal disease (ESRD) (hazard ratio: 10.494, 95% confidence interval: 2.131-51.681) and shorter ascending colon withdrawal time (interval cancer: noninterval cancer 2.00±0.82: 4.91±3.74 minutes; hazard ratio: 0.561, 95% confidence interval: 0.345-0.913). Prior polypectomy and tumor size also tended to be related to interval CRC.
CONCLUSION: The prevalence of interval CRC in the present study is 3.28%. Comorbidity with ESRD and shorter ascending colon withdrawal time could be factors associated with interval CRC. Good colon preparation for the patients with ESRD and more ascending colon withdrawal time could reduce the interval CRC.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  associated factor; colon withdrawal time; end-stage renal disease; incidence; interval colorectal cancers

Mesh:

Year:  2017        PMID: 28420554     DOI: 10.1016/j.jfma.2017.03.012

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  4 in total

1.  The contribution of endoscopy quality measures to the development of interval colorectal cancers in the screening population: a systematic review.

Authors:  Deirdre M Nally; Athena Wright Ballester; Gintare Valentelyte; Dara O Kavanagh
Journal:  Int J Colorectal Dis       Date:  2018-10-29       Impact factor: 2.571

2.  Differences between carcinoma of the cecum and ascending colon: Evidence based on clinical and embryological data.

Authors:  Xin Xie; Zhangjian Zhou; Yongchun Song; Wei Wang; Chengxue Dang; Hao Zhang
Journal:  Int J Oncol       Date:  2018-04-12       Impact factor: 5.650

3.  Colonoscopic withdrawal time and adenoma detection in the right colon.

Authors:  Gee Young Yun; Hyuk Soo Eun; Ju Seok Kim; Jong Seok Joo; Sun Hyung Kang; Hee Seok Moon; Eaum Seok Lee; Seok Hyun Kim; Jae Kyu Sung; Byung Seok Lee; Hyun Yong Jeong
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

Review 4.  Aptamer‑based therapy for targeting key mediators of cancer metastasis (Review).

Authors:  Yahya Alhamhoom; Homood M As Sobeai; Sary Alsanea; Ali Alhoshani
Journal:  Int J Oncol       Date:  2022-04-15       Impact factor: 5.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.